the reports that came out about roches tamiflu sales were disputed - so what do we make of this? - i imagine they mean up from same q last yr rather than last q
heres earlier post with roche report
Sales of Roche's flu drug Tamiflu rose 32 percent to 517 million francs in the first three months of the year as the company enjoyed additional demand due to the swine flu pandemic.
Other makers of flu drugs and vaccines, such as GlaxoSmithKline Plc (GSK.L), Sanofi-Aventis SA (SASY.PA) and Novartis AG (NOVN.VX), are also expected to enjoy a first-quarter sales boost, despite recent government moves to cut some vaccine orders due to excess supplies.
BTA Price at posting:
$2.06 Sentiment: LT Buy Disclosure: Held
